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Summary:  
The role of heater cooler units (HCUs) in the transmission of Mycobacterium chimaera 
during open heart surgery has been recognised since 2013. Subsequent investigations 
uncovered a remarkable global outbreak reflecting the wide distribution of implicated 
devices.  HCUs are an essential component of cardiopulmonary bypass operations and their 
withdrawal would severely affect capacity for life-saving cardiac surgery. However, studies 
have demonstrated that many HCUs are contaminated with a wide range of 
microorganisms, including M. chimaera and complex biofilms.  Whole genome sequencing 
of M. chimaera isolates recovered from one manufacturer’s HCUs, worldwide, has 
demonstrated a high level of genetic similarity, for which the most plausible hypothesis is a 
point source contamination of the devices.  Dissemination of bioaerosols through breaches 
in the HCU water tanks is the most likely route of transmission and airborne bacteria have 
been shown to have reached the surgical field even with the use of ultraclean theatre 
ventilation.  Controlling the microbiological quality of the water circulating in HCUs and 
reducing biofilm formation has been a major challenge for many hospitals. However, 
enhanced decontamination strategies have been recommended by manufacturers and 
while not always effective in eradicating M. chimaera from HCUs, UK hospitals have not 
reported any new cases of M. chimaera infection, since implementing these mitigation 
strategies. Water safety groups in hospitals should be aware that water in medical devices 
such as HCUs can act as a vector in the transmission of potentially fatal water-borne 
infections.   
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Introduction and Background  
Mycobacterium chimaera infections following cardiac surgery have been attributed to the 
use of heater-cooler units (HCUs) which form part of the cardiopulmonary bypass 
equipment. Cases have been reported worldwide reflecting the global problem of microbial 
colonisation and the need for effective management of HCUs
1-4
. This review summaries the 
knowledge to date as well as the challenges faced by those who have to prevent and control 
infection. 
 
Burden and history of Non-tuberculous mycobacteria (NTM) 
Water-borne opportunistic pathogens are responsible for a range of infections in 
immunocompromised and vulnerable patients particularly in health-care facilities. 
Organisms including Legionella spp., Pseudomonas aeruginosa and non-tuberculous 
mycobacteria (NTM) have been recovered from water systems 
5-9
 and can cause persistent 
problems in hospitals
10-12
.  
 
NTM as water-borne pathogens 
NTM are ubiquitous within the environment, particularly in natural waters and building 
water distribution systems where they appear to inhabit a similar niche as Legionella spp. 
13-
17
.  However, unlike Legionella, the control of NTM is not covered by any specific legislation 
or guidance 
18
. 
 
Infections caused by rapidly growing NTM  have been reported following cardiac bypass 
surgery 
19-23
, peritoneal dialysis 
24
 and middle ear cleaning 
25
. Individuals tend to be 
predisposed to NTM infection e.g. have comorbidities and/or are immunosuppressed but 
infections are increasingly being seen in otherwise healthy individuals 
26
.  
In the majority of countries, the most common manifestation of NTM infection is sporadic 
pulmonary disease caused by members of the Mycobacterium avium complex (MAC) - a 
group of organisms that includes M. avium, M. intracellulare and M. chimaera 
26-31
.  
 
Members of the MAC are relatively slow growing and can take upwards of 6 weeks to 
culture from patient and environmental samples. Delays in identification and diagnosis, 
coupled with the fact that MAC infections do not require notification to public health teams, 
means that the true burden of these organisms within healthcare facilities in the UK, is 
difficult to quantify. 
 
NTM and cardiac surgery 
Exposure to water droplets aerosolised from contaminated hospital water systems has been 
linked to pulmonary MAC infection 
10, 32-34
 but other routes of infection are possible. In 
1976, NTM infections following cardiac surgery were attributed to porcine heart valves 
contaminated with M. fortuitum and M. chelonae 
35-37
. Inadequate sterilisation had allowed 
NTM to  survive on the surface of porcine valves 
37
. The valves were recalled and, following 
changes in procurement and sterilisation, contamination rates reduced from approximately 
4% to <0.0001%. 
 
In 1992, Hector et al. described four nosocomial outbreaks of M. fortuitum. All  cases 
followed  cardiac surgery and two were attributed to the hospital potable water supplies 
38
. 
To determine the source of a M. wolinskyi bacteraemia and aortic prosthesis colonisation 
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(only 16 days after surgery), Dupont et al., sampled a range of environmental surfaces and 
water sources 
39
.  Although M. wolinskyi was not recovered, M. chelonae, M. mucogenicum, 
and M. llaterense were detected in potable water sources. 
 
HCUs as reservoirs of NTM 
The first report of M. chimaera infections following cardiac surgery was published in 2013 
40
. 
A follow-up investigation by Sax et al., described a total of 6 M. chimaera prosthetic valve 
endocarditis or vascular graft infections and an epidemiological link to HCUs utilised during 
surgery 
1
. Since then,  additional reports of M. chimaera infections associated with the use 
of HCUs have emerged from Australia 
2, 41
, Canada 
42
, France 
43
, Germany 
44
, Hong-Kong 
45
, 
Ireland 
43
, Netherlands 
44
, Spain 
43
 Switzerland 
44
, UK 
4
 and United States 
46, 47
, reflecting the 
global use of these devices.   
 
Interestingly, the potential significance of HCUs in infection control was determined as early 
as 2002 in a publication that highlighted HCU microbial contamination, malfunctions, 
possible patient exposure routes, incompatibility of biocides with HCU components and 
problems regarding effective decontamination 
48
. These are all issues that are again 
discussed in light of recent investigations 
4, 49
.  
 
What is a heater cooler and how do they operate? 
HCUs are integral for cardiopulmonary bypass operations and can be used for 
extracorporeal membrane oxygenation (ECMO) or extracorporeal life support (ECLS) 
50
.  
They have two or three interconnected cold and warm water tanks which function in 
combination, to deliver temperature-controlled water to external heat exchangers 
associated with cardioplegia and oxygenation equipment as well as the patient heating 
blanket (Figure 1). The temperature difference between the water circulated by the HCU 
and the blood determines heat transfer and regulates the temperature of the blood 
perfusing the patient. Heat exchangers should prevent any contact between the HCU water 
and the patient, although rare leaks causing infection have been described 
51, 52
. The sealed 
water tanks contain a number of different materials such as plastic tubing, insulation 
material, stainless steel and copper. Some models have two overflow pipes which can be 
used to vary the volume of water contained within (Figure 2). However, as only one of these 
overflow pipes is used at any one time, the other becomes a dead-leg, resulting in 
stagnation of water, debris accumulation and formation of biofilm.  The overflow bottle and 
the dead-leg which are usually filled with tank water must also be included in the 
decontamination regimen. 
 
Determining the source of infections related to HCUs 
The water circulating in an HCU can contain a wide range of microorganisms.   Extremely 
high heterotrophic plate counts (> 10
8
 cfu/L) comprising a range of environmental Gram-
negative organisms including P. aeruginosa, Sphingomonas paucimobilis, Stenotrophomonas 
maltophilia and Brevundimonas vesicularis have been reported 
4, 49
. Other opportunistic 
pathogens including M. chelonae, Aspergillus flavus and non-aspergillus moulds 
(Paecilomyces spp) have also been identified. The presence of L. pneumophila has also been 
detected 
4, 39, 49, 53
. The aerosolisation of L. pneumophila could represent a risk to users and 
surrounding staff 
48
. However, in the UK, no cases of Legionnaires’ disease associated with 
HCUs have been identified 
4
. The presence of high numbers and a diverse range of 
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microorganisms within an HCU is likely to facilitate the formation of extensive biofilms on 
tubing associated with the water tanks (Figure 5) 
4, 49
. 
 
During their outbreak investigations, Sax et al., recovered M. chimaera from water taken 
from 5 different HCUs 
1
. Similar randomly amplified polymorphic DNA polymerase chain 
reaction (RAPD-PCR) patterns were observed in isolates recovered from one of these HCUs 
and an associated air sample implying the aerosolisation of M. chimaera from within the 
unit. However, no isolate recovered from any of the HCUs was an exact match to that from 
an infected patient and it was hypothesised that this was due to the long time lag between 
patient exposure and the sampling of the HCU 
1
. Samples taken from drinking water 
fountains were also positive for M. chimaera but it was concluded that drinking water was 
unlikely to be responsible for the invasive infections. Chand et al., sampled 45 HCUs across 
12 different UK hospitals and nineteen (42%) were positive for M. chimaera. The results of 
these and other studies suggest that M. chimaera is a common contaminant of HCUs and 
that contaminated water within a HCU could be the source of M. chimaera infections 
2, 3, 49, 
54
. 
 
To date, all M. chimaera infections have been attributed to a specific make/model of HCU 
(Sorin 3T, LivaNova PLC, formerly Sorin Group Deutschland GmbH).   M. chimaera has been 
recovered from in-use 3T HCUs within hospitals worldwide 
1, 2, 4, 43, 44, 55, 56
, from new unused 
3T HCUs, and from water samples obtained at the manufacturing site of LivaNova PLC
53
.  
However, microbial contamination of HCUs is widespread and is not specific to particular 
manufacturers or models 
4, 57
. Such contamination implies a systemic failure of the 
decontamination regimen resulting in the formation of biofilms. The environmental 
conditions and usage of the HCU favours the growth of a wide range of microorganisms 
4, 49, 
54
.  In operating theatres, the HCU is set up and connected to allow water to circulate 
through the unit, tubing, cardioplegia equipment and oxygenator some hours prior to the 
entry of the patient. This gives time to ensure that all the equipment is operating 
appropriately but also for the temperatures to stabilise. The temperature of the water 
circulating in the HCU can be as high as 40°C; this temperature encourages bacterial growth 
and formation of biofilm 
4, 49
. When not in use the 3T HCUs are stored at ambient 
temperatures allowing bacterial survival and proliferation of the biofilm in the stagnant 
water particularly on pipe materials and inside the water tanks (Figure 2 and 5). Biofilms 
produce extensive extracellular polysaccharides (EPS) which presents a physicochemical 
barrier to the penetration of disinfectants 
58
. As such the tolerance of biofilms is thought to 
be associated with the quenching of disinfectants as they pass through the EPS and due to 
the presence of slow growing or persistor cells that have reduced susceptibility to many 
disinfectants and other antimicrobials 
59-61
. Resistance to disinfectants may also be due to a 
genetic characteristics acquired either by mutation or by gene exchange 
62
. 
 
In terms of mycobacteria, the presence of a high cell surface hydrophobicity may result in 
their preferential attachment to surfaces at air-water interfaces and may contribute to 
disinfectant tolerance of NTM within the HCU 
63
. Hydrophobicity varies between MAC 
species 
64
. Both M. avium and M. intracellulare are recovered more frequently from pipe 
surfaces in biofilms, than in the planktonic phase 
65, 66
. However, M. intracellulare forms 
biofilms more readily than the less hydrophobic M. avium, which is more commonly found 
in the bulk water 
65, 67
.  The presence of NTM biofilms in HCUs makes their decontamination 
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extremely challenging and hospitals are still reporting intermittent positives of heater-
cooler units despite complying with the recommended disinfection procedure(s) (J Walker 
personal communication).  
 
Despite the global distribution and use of 3T HCUs, whole genome analysis has 
demonstrated a lack of genetic diversity between isolates 
2, 4
.  In Australia, M. chimaera was 
recovered from 10 HCUs across four different hospitals 
2
. Representative isolates clustered 
into two groups which differed by 28 single nucleotide polymorphisms (SNPs), with 2–17 
SNP differences between isolates within a single group 
2
. Recent evidence also suggests that 
a high level of DNA sequence conservation (equivalent to 6 SNPs) exists between isolates 
recovered from the southern and northern hemispheres 
55
. During an outbreak investigation 
in the US, genomic analysis identified a maximum of 38 SNPs between any two isolates in 
the outbreak. Of the 261 isolates examined by Chand et al, 94%, including all those from 
probable cases and 86% of isolates from 3T HCUs clustered very closely (mean pairwise 
distance of 10 SNPs) 
4
.  In comparison, a minimum of 2,900 SNPs were detected between 
any single outbreak isolate and an epidemiologically unlinked isolate 
3
. Such data strongly 
indicate a point source for the contamination of HCUs i.e. that the LivaNova 3T units were 
contaminated within the manufacturing site 
2, 4
. Preliminary data from Haller et al supports 
this hypothesis 
54
. However, Svensson et al., 2017  provided evidence that HCUs from other 
manufacturers (e.g. Maquet) have cultured M. chimaera 
57
.  However, these M. chimaera 
isolates were genetically distinct (47-49 SNP differences) compared with isolates from the 
Sorin 3T HCUs and have not been linked with any clinical cases. In addition, other 
manufacturer units have been shown to be positive for M. chimaera which indicates that 
there may be alternative routes to contaminating the HCU, to that of a manufacturing, point 
source 
57
. Indeed, the water supplies within hospitals used to fill HCUs cannot be excluded 
as a source of M. chimaera contamination 
1, 2
 and reinforces the need for implementing a 
water safety plan and decontamination strategies by the water safety group 
18
.  
 
 
Airborne transmission of M. chimaera from HCUs to the surgical site  
Robinson et al., identified a genetic relatedness between 10 HCU M. chimaera isolates from 
four hospitals, but a patient M. chimaera isolate was not genetically related to the HCU M. 
chimaera isolates from that hospital, nor to the other HCU isolates; indicating that the HCUs 
were not the source of the infection in that patient 
2
.  However, a high genetic similarity 
between M. chimaera isolates recovered from HCUs and patients in other studies is 
consistent with a role for HCUs in transmission 
 57
.  
 
Sax et al., hypothesized that contaminated water leaking from the circulation tubing or 
connectors can reach the turbulent airflow produced by fans in the lower body of the HCU 
1
.  
Gotting et al., also attributed the aerosolisation of water droplets to the operating fans; 
specifically a fan located in the upper rear part of the HCU 
68
.  Public Health England, Porton 
Down, carried out a controlled laboratory study to investigate the microbial aerosols 
generated by a naturally contaminated (decommissioned) 3T HCU that had been in service 
since 2002 
4
. A high volume cyclone air sampler was used to confirm that the HCU released 
a bioaerosol.  
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As was also demonstrated by Sax et al. this aerosol significantly increased with circulation of 
water and the highest level of aerosol was detected at the rear of the HCU 
1
. An 
aerodynamic particle sizer was used to carry out a more detailed examination of the HCU. A 
series of holes close to the flow and return pipes of both water circuits and a gap between 
the tank sealing plates were identified as areas of significant aerosol release (Figure 3). Flow 
visualisation demonstrated the movement of smoke particles from these areas to the 
outside environment via the operation of a small cooling fan at the rear of the HCU (Figure 
4a and 4b). To date, these holes have only been observed in 3T HCUs manufactured before 
2004 and may be due to the sealing plates shifting over years of operation. When the holes 
were sealed with mouldable putty the production of aerosols was greatly diminished 
4
. 
 
Sommerstein et al., investigated the dispersal of M. chimera from a 3T HCU in a fully 
functional cardiac theatre fitted with an ultraclean air ventilation system validated to ISO EN 
14644–3:2005. The vertical flow of laminar air from the ceiling should prevent aerosols from 
entering the operating field 
69
. The authors investigated aerosol transmission using a 
particle counter, a thermic anemometer, smoke dispersal and microbial monitoring when 
the HCU was switched off and when it was operating.  When the HCU was operating and 
orientated such that its exhaust airflow (at the rear of the unit) was directed towards the 
surgical field, smoke from a source 20 cm from the HCU penetrated the ultraclean 
ventilation system and reached the operating field. This correlated with increased particle 
counts and the detection of M. chimera (settle plates) up to 5m from the HCU. By combining 
these results with previous work using active air samplers, Sommerstein et al., concluded 
that the concentration of mycobacteria in the air was high enough to contaminate implant 
devices in the surgical field 
1, 69
. 
 
Clinical features and diagnosis  
A number of investigations have demonstrated an increased risk of invasive M. chimaera 
infection in patients who have undergone cardiothoracic surgery, particularly valve 
replacement or repair 
1, 4, 44
.  Although infections following coronary artery bypass grafts 
(CABG), vascular grafts, heart transplant, and left ventricular assist devices have been 
identified,  risk assessment suggests heart valve repair and replacement carry the highest 
risk 
70
.  A number of disseminated infections and secondary focal infections such as discitis 
have been reported 
4, 44, 70
.   Patients affected have been primarily but not exclusively adults 
4, 44
 with a median age of 61 (range 36-76 years) which may reflect the age of those likely to 
require valve replacement surgery 
44
. The interval from surgery to diagnosis has ranged 
from 3 months to 6 years with a median interval of 17-18 months 
1, 4, 70
. 
 
Estimated risk of infection varies, in part a likely reflection of under-ascertainment of cases 
4
. Estimates from affected centres in Switzerland and the USA range from 1 per 100 to 1 per 
1000 
1, 56, 71
. In England, national risk assessment was possible through access to national 
health datasets. This identified an overall risk per patient undergoing heart valve surgery of 
1 in 5,000 between 2007-2015, although rising over time to reach 1 in 2,000 in 2014 
72
.  
  
Patient outcome has been described as poor, which is probably multifactorial from late 
diagnosis and treatment, intrinsic drug resistance of M. chimera biofilm which may hinder 
the penetration and action of antimicrobials in the cardiac and pulmonary tissue 
44, 73
.  
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M. chimaera may also be misidentified which could result in an underestimation of the 
number of cases. M. chimaera and M. intracellulare are genetically similar and most 
commercially available laboratory assays cannot differentiate M. chimaera from M. 
intracellulare. When 149 M. intracellulare isolates were reanalysed using 16S rRNA 
sequencing, 63 % of them were found to be M. chimaera, 
74
.  Reanalysis of M. intracellulare 
isolates from relevant sites in cardiothoracic patients may result in an increase in M. 
chimaera cases. 
 
 
How to prevent and control contamination of HCUs 
 
Compatibility of manufacturer’s equipment  
To compound the issue of decontamination, hospitals using 3T HCUs with oxygenators 
manufactured by a different manufacturer (Maquet) have been informed that H2O2 should 
not be used as a disinfectant 
75, 76
. Tests  had shown that the diffusion rate of H2O2 through 
the Maquet oxygenator heat exchangers (polyurethane hollow fibres) can result in amounts 
of diffused H2O2 that exceed the daily allowable limits 
75
. Alternative chemicals 
recommended for the disinfection of HCUs by LivaNova include peracetic acid, however, a 
number of hospitals have concerns regarding the occupational exposure of staff to peracetic 
acid and are using clorina (active ingredient sodium p-toluenesulfonchloramide, 
recommended for Maquet oxygenators) for both the Maquet oxygenators and HCUs.  
However, hospitals should be aware that the advice from the regulator in the UK (MHRA) is 
to follow the manufacturer’s instructions for cleaning and disinfecting these devices and the 
associated components at all times, as the impact on the safety and performance of the 
devices are unknown and such activities may invalidate the manufacturers’ warranty 
77
. 
 
Decontamination recommendations 
To date, all M. chimaera infections have been attributed to the 3T HCUs. However, microbial 
contamination of HCUs is widespread and is not specific to particular manufacturers or 
models 
4, 57
. Such contamination implies a systemic failure of the decontamination regimen 
resulting in the formation of biofilms. The environmental conditions and usage of the HCU 
favours the growth of a wide range of microorganisms 
4, 49, 54
.  All manufacturers provide 
advice for sampling and decontamination of heater coolers on their websites. 
 
In terms of the 3T HCU, in 2015 LivaNova advised the following: decant HCUs of water every 
two weeks, refill with filtered (0.2 µm) tap water and add 100 mL of medical grade 3% 
hydrogen peroxide (H2O2) to the HCU tanks.  50 mL of 3% H2O2 should then be added every 
five days. A full system HCU decontamination using Maranon (>30% sodium hypochlorite) 
was advised every three months 
78
.  There was also a change in the cleaning and disinfection 
guidance in 2015 to require more frequent disinfection of the water circuit (i.e. disinfection 
every two weeks rather than every 3 months) with specified disinfectant solutions including 
peracetic acid; weekly water changes; and the addition of hydrogen peroxide solution to the 
water to act as a preservative and to further prevent biofilm formation 
49, 79
.  In terms of 
microbiological sampling LivaNova advised users to sample the water prior to disinfection 
for heterotrophic bacteria, coliforms, P. aeruginosa and NTM. During usage in the 
operating theatre, users were also advised to carry out biweekly microbiological water and 
air sampling. 
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Efficacy of decontamination assessed by microbiological testing  
Studies have indicated that the decontamination procedures provided by the manufacturer 
do not sufficiently inhibit the growth of microorganisms in HCUs 
49, 79
.  Garvey et al., found 
that using the initial decontamination advice provided by the manufacturer, environmental 
Gram-negative bacteria, Pseudomonas spp., fungi and M. chimaera were recoverable from 
the HCU 
49
.  Working with the manufacturers, Garvey et al., carried out two consecutive full 
system HCU decontamination cycles with Maranon (420 mL, >30% sodium hypochlorite). In 
addition the HCUs were subjected to weekly water changes (with filtered tap water), daily 
addition of medical grade 3% H2O2 (100 mL) and a weekly full system decontamination using 
Maranon. However, based on the manufacturer’s guidance, water samples from the HCU 
remained microbiologically unacceptable 
49
.  
 
It was only after complete refurbishment and replacement of the internal tubing by the 
manufacturer, followed by the application of the disinfection regimen; that the weekly HCU 
microbiological sampling counts reduced to a satisfactory level
52
. The addition of an 
effective disinfectant to a HCU with minimal biofilm (either because it is new or refurbished) 
would be expected to control the survival and growth of water-borne microorganisms which 
may explain the lack of detection of M. chimaera from HCUs after refurbishment by 
LivaNova 
49
. In addition, the daily water changes and subsequent dilution of slow growing 
NTM may have resulted in the bacterial numbers being below the level of detection in water 
and air sampling 
49
.  Replacement of the internal tubing and renovation of the HCUs is a 
service that is offered by the manufacturer as a way of eradicating M. chimaera from the 
units.  However, this service is only available for units that were manufactured after 2008 
and there is an associated cost. More recently a number of perfusionists in the UK have 
been trained by the manufacturer to undertake this refurbishment (J Walker – personal 
communication).  
 
Whilst enhanced disinfection may fail to eradicate NTM in water or biofilm phase, Schreiber 
et al., found that aerosolised M. chimaera were not detectable in brand new HCUs that 
were undergoing the manufacturer recommended enhanced disinfection regime, 
60
 
suggesting that the infection risk via this route may have been reduced.  To date there has 
been no detailed investigation of risk to patients in terms of the number of M. chimaera in 
the water phase compared to the number present in aerosols which would have assisted in 
the establishment of a risk assessment based on quantifiable results. 
 
It is clear that the increased disinfection and sampling regimens recommended by the 
manufacturer have added a considerable burden of duties and costs for perfusionists, 
cardiology and theatre staff. The microbiological analysis, air sampling, air filters and 
disinfectants have been estimated at £34,391.54 per year for one UK hospital operating 
eight LivaNova 3T HCUs (Table 1) (J Walker - personal communication).  In addition, 
conversion of an existing space to be used for decontamination has also been estimated by 
that hospital to cost an additional £28,444.    
 
Whilst disinfection has not completely removed the presence of M. chimaera in the water 
tanks, there has so far, been no new cases of M. chimaera infections identified originating 
from surgery since the introduction of the enhanced decontamination strategies. However, 
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it may still be too early to speculate as we remain well within the recognised incubation 
period for the infection.  Indeed other NTM strains, notably M. abscessus linked to hospital 
tap water, have also been associated with cardiac surgery patient infections  
80
.  
 
HCU containment and relocation strategies 
Reliable, effective decontamination of HCUs and maintaining the microbiological quality of 
the water is difficult and many hospitals have adopted alternative control strategies.  In line 
with guidance, hospitals have been positioning the HCU as far from the patient area as is 
feasible, as well as directing the rear fan away from the operating field and where possible 
close to an air extraction port in the theatre 
81
.  An alternative approach involves enclosing 
the water reservoirs and tubing of the HCU within an air tight ‘biosafety box’ and extracting 
the air from within the box to the outside of the theatre 
82
. Another is to place the HCU 
outside of the operating theatre. Gotting et al. 
68
 positioned the HCU through a doorway, 
however, the positioning of the tubing connecting the cardiopulmonary bypass machine to 
the HCU prevented the theatre door from closing. This may have been the reason why the 
air samples from the operating room were positive and underlines the importance of 
controlling air flow in the whole operating area.  
 
In Bern University Hospital, four new cardiac operating theatres have been built with ante-
rooms specifically designed for housing the HCUs in 2009 prior to the current M. chimaera 
outbreaks 
82
.  The tubing passes into each operating room via cavities in the walls removing 
the risk of exhaust air from the HCU entering the operating room 
82
. A UK hospital has 
recently taken a similar approach by building modular plates into the walls that seal the 
tubing passing through the wall (Figures 6 & 7). The costs of this intervention, including 
revalidation of the theatre air flows, have been estimated at £15,000.  Figures 6 & 7 also 
show the newly recommended polyethylene tubing (blue) for use with the HCUs to try to 
reduce biofilm formation.  Perfusionist’s comments are that the tubing is less flexible and 
being opaque the perfusionists are unable to see if there has been a blood/water breach in 
the system (J Walker – personal communication).  
 
Assessment and revalidation of the operating theatre airflows is essential to ensure that 
they are not disrupted by any changes.  The use of longer lengths of tubing can cause 
further complications such as the requirement for larger volumes of water, inefficient heat 
transfer and the inability to maintain temperature control with the additional possibility of 
increased trips and falls. Any containment and relocation strategy should involve the 
manufacturer. 
 
In due course the manufacturers may be able to i) implement an engineering solution to 
upgrade existing devices to prevent dissemination of aerosols from the HCUs and or ii) 
design new HCUs to prevent the growth of NTM in the water and to ensure that 
aerosolisation is minimalised during the operation of the HCU. However, these units should 
be fully tested and validated for microbial control and aerosol containment by independent 
and objective scientists. 
 
Implications for other thermoregulatory equipment 
The concern surrounding post-surgical M. chimaera infections had until recently, been 
limited to HCUs. However, heater cooler units are also used for extracorporeal membrane 
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oxygenation (ECMO) and similar thermoregulatory devices are also required for circulating-
water mattress to maintain body temperature 
50, 83
. M. chimaera was detected in 9 of 18 
water samples taken from 10 different heater cooler units used for ECMO devices 
50
. Of 76 
ECMO patients who had bronchial specimens analysed for mycobacteria, M. chimaera was 
found in three individuals without signs of mycobacterial infection at the time of sampling. It 
would be prudent for water safety groups to ensure that HCUs used in ECMO are assessed 
as part of the water safety plans to ensure that the risk is reduced for those who may be 
exposed via this route.  
 
In summary 
There is an ongoing international outbreak of M. chimaera infection following cardiac 
surgery. Whilst a transmission risk has been identified, it is essential to recognise that many 
cardiac procedures, which can be life saving, are dependent on these devices. The low risk 
of infection must be balanced with usually much higher risks from delaying surgery. 
 
The genetic similarity between case (patient) and environmental isolates supports the 
hypothesis that M. chimaera is transmitted to the surgical site via the aerosolisation of 
contaminated water from within HCUs.  The water tanks of HCUs have been shown to 
contain a wide variety of microorganisms including extensive biofilms on a number of 
different components which likely contributes to the survival of M. chimaera. 
 
The evidence from whole genome sequencing of M. chimaera in the UK, USA, Australia/New 
Zealand and Europe has demonstrated close relatedness between patient and device 
isolates, supporting the hypothesis of transmission from the HCUs and suggestive of a point 
source outbreak from the manufacturer’s factory; within a wider potential risk of microbial 
transmission from this type of device. Rigorous disinfection regimens have been 
recommended by the different manufacturers, but these protocols and microbiological tests 
can be time consuming and resource intensive for hospitals, both in terms of personnel and 
cost.  
 
Whilst disinfection has not completely removed the presence of M. chimaera in the water 
tanks, there has so far, been no new cases of M. chimaera infections identified originating 
from surgery after the introduction of the enhanced decontamination strategies. However, 
it may still be too early to speculate and indeed other NTM strains, notably M. abscessus 
linked to hospital tap water, have been associated with cardiac surgery patient infections. 
Therefore, in order to reduce the risk of future infection, it is critical that hospitals are 
aware of the risk and follow strict decontamination procedures of HCUs.  Water safety 
groups should work with users to ensure control of microbiological risks from heater cooler 
units, and that water system management is embedded in routine infection control practice.  
 
It is not clear why M. chimaera is currently the dominant clinical infection, when other 
species of NTM are found regularly within the HCUs. It may be an artefact of methods used 
for surveillance, may relate to M. chimaera being more widespread rather than being only 
from a point source, or perhaps may relate to as yet an undescribed biological characteristic 
of the species facilitating survival either in the HCU or the patient.  
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Table 1 Estimated costs for one hospital to undertake testing of eight LivaNova 3T 
heater-cooler units. 
Microbiological analysis / Air 
sampling  
Estimated cost per 
month or every 3 
months 
Annual Costs  
Legionella (water) £18 x 8 samples (every 
3 months) 
£576.00 
Pseudomonas aeruginosa (water) £7.65 x 8 samples 
(every month) £734.00 
 
Environmental Mycobacteria 
(water) 
£50.40 x 8 samples 
(every month) £4838.00 
 
Total air analysis costs for 8 
machines 
£150 x 8 machines 
(every month) £14,400.00 
 
Water filters  Box of 2 for 2 outlets per 
year 
£903.00 
 
Peracetic acid  For 8 units over one 
year 
£1326.00 
 
Staff time  For 8 units over one 
year 
£11,614.50 
Total   £34,391.50 (excl 
VAT)  
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Figure 1. Schematic of a typical heater cooler unit, oxygenator and cardioplegia 
equipment 
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Figure 2.  Two overflow pipes which can be used to vary the volume of water in 
LivaNova 3T HCU tanks. The lower pipe takes the overflow (and visible debris) from 
the tank to the overflow bottle that is attached to the rear of the HCU. The upper pipe 
is blocked at the top and contains stagnant water, biofilm and debris. 
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Figure 3. Location of the gaps in the water tank top plates that contributed to the 
release of aerosols from the heater-cooler unit studied by Public Health England, 
Porton Down. 
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Figure 4a.  Use of a smoke pen to visualise air flow path as it is extracted from the 
pumps/gaps associated with the water tanks and exiting the heater-cooler unit via 
the rear fan.  
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Figure 4b.  Video of smoke pen to visualise air flow path as it is pulled away from the pumps and gaps 
associated with the water tanks to the rear fan and as it is excited from the HCU. 
mycobacteria hcu review Figure 4b air path video.avi
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Figure 5. Presence of extensive biofilm on materials in the water tanks of the 
LivaNova PLC, Sorin 3T heater-cooler unit, studied at Public Health England, Porton 
Down.  
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Figure 6.  Positioning of the heater-cooler unit outside the operating theatre with 
tubing passing through modular plates in the wall. 
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Figure 7. Position of the tubing through the wall into the operating theatre, using anti-
slip matt housing and connection to the cardiopulmonary bypass equipment. 
 
  
